UPDATE: Rhythm Pharmaceuticals (RYTM) PT Raised to $23 at Ladenburg Thalmann; 'H.O. Data Is Imcivree’s Best Yet, With Biggest Market Opportunity'
Tweet Send to a Friend
(Updated - July 13, 2022 6:54 AM EDT)
Ladenburg Thalmann analyst Michael Higgins raised the price target on Rhythm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Ladenburg Thalmann analyst Michael Higgins raised the price target on Rhythm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
